SEKO Logistics’ new operation in Ireland has won a three-year contract to serve as Peli BioThermal™’s network station and service centre in Dublin, connecting the leader in temperature-controlled packaging with pharmaceutical clients across the country.

The Master Services Agreement will see SEKO Logistics’ team service, refurbish, repair and condition Peli BioThermal’s Crēdo™ on Demand shippers, which ensure delicate biological life science materials arrive intact and effective, protected from exterior environments.

Work will be carried out in SEKO’s Good Distribution Practice (GDP) compliant warehouse in Dublin by GDP-trained staff who have been certified by Peli BioThermal’s specialists. SEKO will also use a team of GDP-trained drivers to distribute the temperature-controlled, preconditioned and validated containers for loading to shippers across Ireland, which is home to many of the world’s leading bioptech and pharma companies.

The solution extends SEKO Logistics’ own healthcare logistics services for medical device manufacturers, biotechnology, clinical trials and pharmaceutical companies, which have chosen SEKO to handle high value medical, surgical, diagnostic and imaging equipment.

In Dublin, SEKO is now responsible for delivering Peli BioThermal’s commitment to provide high performance, flexible rental options for its Crēdo™ Cargo, Crēdo™ Xtreme and Crēdo™ Cube temperature-controlled packaging – a choice of applications designed to suit all pharmaceutical shipper requirements.

Michael Daly, Managing Director of SEKO Logistics in Ireland, said: “SEKO already has a global reputation for high quality MedTec solutions so we understand the strict requirements of the medical and pharma industries. As Peli BioThermal’s sole service centre operation in Ireland, we will ensure their customers here receive the same level of service quality, worry-free management, availability and flexibility that is the hallmark of Peli BioThermal’s growing choice of network stations around the world.”

SEKO Logistics opened its own operation in Ireland – one of Europe’s fastest-growing economies – in January 2019 as part of its continuing core market investment strategy.